The Cancer Stem Cell Inhibitor Napabucasin (BBI608) Shows General Cytotoxicity in Biliary Tract Cancer Cells and Reduces Cancer Stem Cell Characteristics.

Marlena Beyreis; Martin Gaisberger; Martin Jakab; Daniel Neureiter; Katharina Helm; Markus Ritter; Tobias Kiesslich; Christian Reinhard Mayr

doi:10.3390/cancers11030276

The Cancer Stem Cell Inhibitor Napabucasin (BBI608) Shows General Cytotoxicity in Biliary Tract Cancer Cells and Reduces Cancer Stem Cell Characteristics.

Marlena Beyreis (Erstautor/-in)
, Martin Gaisberger (Co-Autor/-in)
, Martin Jakab (Co-Autor/-in)
, Daniel Neureiter (Co-Autor/-in)
, Katharina Helm (Co-Autor/-in)
, Markus Ritter (Co-Autor/-in)
, Tobias Kiesslich (Co-Autor/-in)
, Christian Reinhard Mayr^* (Letztautor/-in)

^*Korrespondierende/r Autor/-in für diese Arbeit

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

19 Quellenangaben (Web of Science)

Originalsprache	Englisch
Fachzeitschrift	Cancers
Jahrgang	11
Ausgabenummer	3
DOIs	https://doi.org/10.3390/cancers11030276
Publikationsstatus	Veröffentlicht - 2019

Zugriff auf Dokument

10.3390/cancers11030276

1 Abgeschlossen

Evaluierung von Napabucasin als direkten Inhibitor von Krebsstammzellen des Gallenwegskarzinoms
Kiesslich, T. (Weitere Forschende), Mayr, C. R. (Weitere Forschende) & Beyreis, M. (Weitere Forschende)
1/12/16 → 1/12/17
Projekt: Forschung

Dieses zitieren

@article{399f10d8758b46a2ab59afe302bc6045,

title = "The Cancer Stem Cell Inhibitor Napabucasin (BBI608) Shows General Cytotoxicity in Biliary Tract Cancer Cells and Reduces Cancer Stem Cell Characteristics.",

keywords = "SELF-RENEWAL, ID PROTEINS, DIFFERENTIATION, SUPPRESSION, EXPRESSION, PROGNOSIS, GROWTH, TUMORS",

author = "Marlena Beyreis and Martin Gaisberger and Martin Jakab and Daniel Neureiter and Katharina Helm and Markus Ritter and Tobias Kiesslich and Mayr, \{Christian Reinhard\}",

note = "Beyreis, Gaisberger, Jakab, Ritter, Kiesslich, Mayr: Institute of Physiology and Pathophysiology; Neureiter, Helm: Institute of Pathology; Kiesslich, Mayr: Department of Internal Medicine I; all: Paracelsus Medical University, Salzburg, Austria",

year = "2019",

doi = "10.3390/cancers11030276",

language = "English",

volume = "11",

journal = "Cancers",

issn = "2072-6694",

publisher = "MDPI",

number = "3",

}

The Cancer Stem Cell Inhibitor Napabucasin (BBI608) Shows General Cytotoxicity in Biliary Tract Cancer Cells and Reduces Cancer Stem Cell Characteristics. / Beyreis, Marlena (Erstautor/-in); Gaisberger, Martin (Co-Autor/-in); Jakab, Martin (Co-Autor/-in) et al.
in: Cancers, Jahrgang 11, Nr. 3, 2019.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - The Cancer Stem Cell Inhibitor Napabucasin (BBI608) Shows General Cytotoxicity in Biliary Tract Cancer Cells and Reduces Cancer Stem Cell Characteristics.

AU - Beyreis, Marlena

AU - Gaisberger, Martin

AU - Jakab, Martin

AU - Neureiter, Daniel

AU - Helm, Katharina

AU - Ritter, Markus

AU - Kiesslich, Tobias

AU - Mayr, Christian Reinhard

N1 - Beyreis, Gaisberger, Jakab, Ritter, Kiesslich, Mayr: Institute of Physiology and Pathophysiology; Neureiter, Helm: Institute of Pathology; Kiesslich, Mayr: Department of Internal Medicine I; all: Paracelsus Medical University, Salzburg, Austria

PY - 2019

Y1 - 2019

KW - SELF-RENEWAL

KW - ID PROTEINS

KW - DIFFERENTIATION

KW - SUPPRESSION

KW - EXPRESSION

KW - PROGNOSIS

KW - GROWTH

KW - TUMORS

U2 - 10.3390/cancers11030276

DO - 10.3390/cancers11030276

M3 - Original Article

C2 - 30813586

SN - 2072-6694

VL - 11

JO - Cancers

JF - Cancers

IS - 3

ER -

The Cancer Stem Cell Inhibitor Napabucasin (BBI608) Shows General Cytotoxicity in Biliary Tract Cancer Cells and Reduces Cancer Stem Cell Characteristics.

Zugriff auf Dokument

Projekte

Evaluierung von Napabucasin als direkten Inhibitor von Krebsstammzellen des Gallenwegskarzinoms

Dieses zitieren